MassMutual elects Karen Bechtel to its board of directors
Ms. Bechtel is Managing Director of global alternative asset manager The Carlyle Group.
Ms. Bechtel joined Carlyle in 2005 as the head of the Global Healthcare team and currently is focused on corporate buyout opportunities within the private equity market.
Prior to her role at Carlyle, for 28 years, she held a variety of leadership roles within Morgan Stanley & Co., including as Managing Director of the Private Equity Group.
During her esteemed career with Morgan Stanley, she was also co-head of the Financial Sponsors Group and head of the Corporate Restructuring Group, with a strong focus on healthcare investments as well as mergers and acquisitions.
She was also a member of the firm’s Investment Banking Operating Committee.
In addition to her role as a new MassMutual Director, she serves on the Boards of Ortho Clinical Diagnostics, HCR-ManorCare, and Pharmaceutical Product Development, LLC.
She is also a former Board member of Healthscope Ltd., Grupo Qualicorp, Multiplan, Inc., and LifeCare. Mergers & Acquisitions magazine in 2015 named her one of the Most Influential Women in mid-market M&A.
Ms. Bechtel received her bachelor’s degree in mathematics from the University of Texas at Austin and earned her MBA from the Harvard Graduate School of Business. ■
What to read next
LATEST MOVES FROM Massachusetts
- Haemonetics Corporation appoints Robert E. Abernathy to board
- Tetraphase Pharma appoints Kamalam Unninayar as CFO
- Boston Biomedical appoints Edgar Braendle as vice president
- Analogic Corporation appoints Joseph Whitters to board
- Eleven Biotherapeutics appoints Richard F. Fitzgerald as interim CFO
More inside POST
FedEx Corporation Q1 income down 10% Earnings